How to use the speech recognition tool?

RSFVEN-330/2010

Retinitis pigmentosa: molecular diagnosis by next generation sequencing

Retinitis pigmentosa: molecular diagnosis by next generation sequencing.

Type: Observational



Status of the trial: Completed

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2013-06-18
  • Closing Date: 2016-09-19

Criteria

Inclusion: probands or family pedigrees with inherited retinal dystrophy

Exclusion: patients or family pedigrees with retinal abnormalities mimiking inherited retinal dystrophy

Children: No

Adults: Yes

Funder Type: public

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: